Forte Biosciences
FBRX
75 hedge funds and large institutions have $289M invested in Forte Biosciences in 2021 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 23 increasing their positions, 14 reducing their positions, and 18 closing their positions.
72% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 18
64% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 14
21% more funds holding
Funds holding: 62 → 75 (+13)
6% more capital invested
Capital invested by funds: $273M → $289M (+$16.1M)
0.19% more ownership
Funds ownership: 2.36% → 2.55% (+0.19%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FAM
Fred Alger Management
New York
|
+$23.8M |
| 2 |
BlackRock
New York
|
+$18.5M |
| 3 |
State Street
Boston,
Massachusetts
|
+$6.54M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$6.06M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$3.28M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$7.62M |
| 2 |
O
OrbiMed
New York
|
-$5.47M |
| 3 |
Millennium Management
New York
|
-$5.11M |
| 4 |
ACM
Altium Capital Management
New York
|
-$4.61M |
| 5 |
BI
BVF Inc
San Francisco,
California
|
-$4.58M |
FBRX Hedge Fund Activity: Q2 2021 in Review
75 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Forte Biosciences (FBRX) for Q2 2021, worth a combined $289M — up 5.9% from $273M a quarter earlier.
Buyers outnumbered sellers: 31 funds opened new FBRX positions and 18 closed out — a net gain of 13 holders — while 23 added to existing stakes and 14 trimmed.
The largest buyer was Fred Alger Management, adding an estimated $23.8M. The largest seller was ArrowMark Colorado Holdings, cutting an estimated $7.62M.
- 75 institutional investors held Forte Biosciences (FBRX) as of Q2 2021, up from 62 in Q1 2021.
- Funds reported $289M of Forte Biosciences stock for Q2 2021, up 5.9% quarter-over-quarter.
- 31 funds opened new Forte Biosciences positions in Q2 2021 and 18 closed out, a net change of +13 holders.
- The largest Forte Biosciences buyer in Q2 2021 was Fred Alger Management, an estimated $23.8M added.
- The largest Forte Biosciences seller in Q2 2021 was ArrowMark Colorado Holdings, an estimated $7.62M sold.
Based on aggregated 13F filings for Q2 2021.